Invizyne Technologies Stock (NASDAQ:IZTC)
Previous Close
$15.50
52W Range
$8.50 - $23.99
50D Avg
$15.57
200D Avg
$14.78
Market Cap
$157.23M
Avg Vol (3M)
$37.03K
Beta
-4.51
Div Yield
-
IZTC Company Profile
Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.